Quality of economic studies of Hep B vaccines needs to improve … Newsletter Article 11 February 2013 Pages: 2 - 2
Risperidone more cost effective than olanzapine in schizophrenia? Wayne Elwood Newsletter Article 11 February 2013 Pages: 3 - 4
Cost issues hinder clopidogrel prescribing for CHD prevention Newsletter Article 11 February 2013 Pages: 4 - 5
‘Pharmaceutical security’ must be pursued in Australia Newsletter Article 11 February 2013 Pages: 5 - 5
UK committee advises GPs to restrict antibacterial prescribing Newsletter Article 11 February 2013 Pages: 6 - 6
Cost-utility analysis of various AF treatment regimens Newsletter Article 11 February 2013 Pages: 7 - 7
Cost of paediatric HIV infection high and varied in the UK Newsletter Article 11 February 2013 Pages: 8 - 8
Cost of paroxetine plus pindolol worthwhile in depression Newsletter Article 11 February 2013 Pages: 9 - 9
Effect of cost education for anaesthetists short-lived? Newsletter Article 11 February 2013 Pages: 10 - 10
Cost of ribosomal vaccine offset by avoided rhinitis episodes Newsletter Article 11 February 2013 Pages: 10 - 10
Routine use of G-CSF not justified in small-cell lung cancer Newsletter Article 11 February 2013 Pages: 11 - 11
Dulling the pain of terminal cancer - any strong opioid will do Newsletter Article 11 February 2013 Pages: 12 - 12
Ritonavir adjunctive therapy maintains QOL in HIV infection Newsletter Article 11 February 2013 Pages: 13 - 13
Benefits of interferon-α-2b outweigh toxicity in multiple myeloma Newsletter Article 11 February 2013 Pages: 13 - 13
Gaucher’s disease affects work productivity and social life Newsletter Article 11 February 2013 Pages: 14 - 14
Isosorbide mononitrate 100mg preferable to 50mg in angina pectoris Newsletter Article 11 February 2013 Pages: 14 - 14
Drug subsidy changes in NZ raise concern for herpes patients Newsletter Article 11 February 2013 Pages: 15 - 15
US activists to protest against ‘Rebetron’ pricing Newsletter Article 11 February 2013 Pages: 16 - 16